Entity
Description
  • Value proposition

    Cell Therapy for All

    TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.

    TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.

    Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.

    Cell Therapy, Stem Cell, Stem cell mass-production, Cell therapy cGMP manufacturing, biomimetic 3D cell culture, and bioreactor stem cell cultivation

  • Original language

    Cell Therapy for All

    TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients.

    TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality.

    Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.

  • TreeFrog Therapeutics I iPS-derived Cell Therapies I Cell Therapy for All

    TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.

  • https://treefrog.fr/
Catalyst interactions
Catalyst TypeTweets Articles
MOVE: Mobility Re-imagined MOVE: Mobility Re-imagined
Other

14 Nov 2024


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Other

12 Apr 2025


Réseau SATT Réseau SATT
Other

8 Oct 2024


Apec Grand Est
Apec Grand Est
Human ressources, Human Resources Services
Apec Grand Est
Human ressources, Human Resources Services
Other

4 Oct 2024


Start Industrie
Start Industrie
Non-profit Organizations
Start Industrie
Non-profit Organizations
Other

22 May 2024


SAYENS
SAYENS
Research, Startup accelerator & VC, Research Services
SAYENS
Research, Startup accelerator & VC, Research Services
Other

11 May 2024


Ministry of Economy
Ministry of Economy
Government Administration
Ministry of Economy
Government Administration
Other

12 Feb 2024


SATT Aquitaine Science Transfert SATT Aquitaine Science Transfert
Other

8 Oct 2024


Lyonbiopôle Auvergne-Rhône-Alpes
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

14 Dec 2023


ALPHA-RLH
ALPHA-RLH
Research, Public business cluster, French Cluster, Research Services
ALPHA-RLH
Research, Public business cluster, French Cluster, Research Services
Other

4 Dec 2023


Social network dynamics
TreeFrog Therapeutics
2 days, 17 hours ago 34

Next week, two of our talented scientists Michèle DAI and Anne Mouré will be attending the TermisEU2025 in Freiburg for an exciting congress theme 'Shaping the future by connecting scientific diversity in tissue engineering and regenerative medicine'.

If you want to learn more about TreeFrog Therapeutics in this field, reach out to Michele and Anne!

#MicrotissueRules #CellTherapyForAll

TreeFrog Therapeutics
2 days, 17 hours ago 57 2

Another week of travelling Froggies comes to a close with lots of learnings and interactions at #BPIEurope by Cyril ROLS and Loanne Milvoy and a late-breaking poster presented by Peter Andersen at #ASGCT2025!

Rest well Froggies!

#CellTherapyForAll

TreeFrog Therapeutics
3 days, 17 hours ago 22

It’s time for our IMAGE OF THE MONTH from our fantastic Imaging team!

Blue skies are starting to arrive, so the team focused in on this beauty!

What do you see?

👍 James Webb Space Telescope's view of a supernova remnants

💡 Multicellular aggregate projecting neurites along a coverslip and into an artifical extracellular matrix, multiphoton microscopy, 3D-shaded projection. Size, approx 400 μm.

🩷 BaBa Blue Sheep: A microscopic look at a rare blue sheep hair before spinning

Or... describe what you see in the comments section!!


Image (c) Nadège Pujol/ Basile Gurchenkov

#CellTherapyForAll #ImagingBeauty

TreeFrog Therapeutics
5 days, 17 hours ago 99 2

It’s #ASGCT2025 and we chose this congress to be the first company to publicly present a clinical-ready delivery strategy for 3D microtissues in cell therapy!

It took 4 years of development with teams right across TreeFrog and we are so proud of all the work they achieved!

The poster was chosen as part of the late-breaking session and Peter Andersen, our Head of R&D will be there to respond to any questions.
Date: May 15, 2025
Time: 5:30 PM – 7:00 PM
Venue: On-site Poster Hall
Title: Development of a Delivery Strategy for Neural Microtissues in Parkinson’s Disease Cell Therapy (#2039)

Check out the press release here
https://lnkd.in/e76Wjkvj


Thanks to all the authors, led by Nicolas Prudon, PhD - Anais MACHADO-HITAU Andrea Sovera Inês Neves Thibault Dufourd Guillaume Dabée Jérôme Hardoüin Caleb Anderson Marlène Martins William Tilmont Lucía Cordero Espinoza Blanche Tamarit Marie Lacaze Jens Schröder, MD PhD Kévin Alessandri Erwan Bezard Emilie Faggiani Maxime Feyeux

TreeFrog Therapeutics
1 week, 1 day ago 134

FR Version Below

Recently, Solenn Guilbert from our analytical development team presented to 250 students and attendees at the Neurocentre Magendie in Bordeaux. The objective was to showcase TreeFrog Therapeutics journey from an academia start-up to an R&D Biotech and highlight the opportunities for a wide variety of profiles needed within the company - from analytical engineers, stem cell biologists, bioproduction engineers and biophysicists to name just a few talents needed to drive the company forward to success.

Thanks for representing us Solenn!

FR version
Récemment, Solenn Guilbert de notre équipe de développement analytique a fait une présentation devant 250 étudiants et participants au Neurocentre Magendie à Bordeaux. L'objectif était de présenter le parcours de TreeFrog Therapeutics, qui est passé d'une start-up académique à une biotech de recherche et développement, et de souligner les opportunités pour une grande variété de profils nécessaires au sein de l'entreprise - ingénieurs analytiques, biologistes des cellules souches, ingénieurs en bioproduction et biophysiciens, pour ne citer que quelques-uns des talents nécessaires pour mener l'entreprise vers le succès.

Merci Solenn!